Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Multiple Targets on the Gln3 Transcription Activator Are Cumulatively Required for Control of Its Cytoplasmic Sequestration.

Identifieur interne : 000A63 ( Main/Exploration ); précédent : 000A62; suivant : 000A64

Multiple Targets on the Gln3 Transcription Activator Are Cumulatively Required for Control of Its Cytoplasmic Sequestration.

Auteurs : Rajendra Rai [États-Unis] ; Jennifer J. Tate [États-Unis] ; Terrance G. Cooper [États-Unis]

Source :

RBID : pubmed:26976442

Descripteurs français

English descriptors

Abstract

A remarkable characteristic of nutritional homeostatic mechanisms is the breadth of metabolite concentrations to which they respond, and the resolution of those responses; adequate but rarely excessive. Two general ways of achieving such exquisite control are known: stoichiometric mechanisms where increasing metabolite concentrations elicit proportionally increasing responses, and the actions of multiple independent metabolic signals that cumulatively generate appropriately measured responses. Intracellular localization of the nitrogen-responsive transcription activator, Gln3, responds to four distinct nitrogen environments: nitrogen limitation or short-term starvation, i.e., nitrogen catabolite repression (NCR), long-term starvation, glutamine starvation, and rapamycin inhibition of mTorC1. We have previously identified unique sites in Gln3 required for rapamycin-responsiveness, and Gln3-mTor1 interaction. Alteration of the latter results in loss of about 50% of cytoplasmic Gln3 sequestration. However, except for the Ure2-binding domain, no evidence exists for a Gln3 site responsible for the remaining cytoplasmic Gln3-Myc(13) sequestration in nitrogen excess. Here, we identify a serine/threonine-rich (Gln3477-493) region required for effective cytoplasmic Gln3-Myc(13) sequestration in excess nitrogen. Substitutions of alanine but not aspartate for serines in this peptide partially abolish cytoplasmic Gln3 sequestration. Importantly, these alterations have no effect on the responses of Gln3-Myc(13) to rapamycin, methionine sulfoximine, or limiting nitrogen. However, cytoplasmic Gln3-Myc(13) sequestration is additively, and almost completely, abolished when mutations in the Gln3-Tor1 interaction site are combined with those in Gln3477-493 cytoplasmic sequestration site. These findings clearly demonstrate that multiple individual regulatory pathways cumulatively control cytoplasmic Gln3 sequestration.

DOI: 10.1534/g3.116.027615
PubMed: 26976442
PubMed Central: PMC4856090


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Multiple Targets on the Gln3 Transcription Activator Are Cumulatively Required for Control of Its Cytoplasmic Sequestration.</title>
<author>
<name sortKey="Rai, Rajendra" sort="Rai, Rajendra" uniqKey="Rai R" first="Rajendra" last="Rai">Rajendra Rai</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Tate, Jennifer J" sort="Tate, Jennifer J" uniqKey="Tate J" first="Jennifer J" last="Tate">Jennifer J. Tate</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Cooper, Terrance G" sort="Cooper, Terrance G" uniqKey="Cooper T" first="Terrance G" last="Cooper">Terrance G. Cooper</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163 tcooper@uthsc.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis</wicri:regionArea>
<wicri:noRegion>Memphis</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26976442</idno>
<idno type="pmid">26976442</idno>
<idno type="doi">10.1534/g3.116.027615</idno>
<idno type="pmc">PMC4856090</idno>
<idno type="wicri:Area/Main/Corpus">000A83</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000A83</idno>
<idno type="wicri:Area/Main/Curation">000A83</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000A83</idno>
<idno type="wicri:Area/Main/Exploration">000A83</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Multiple Targets on the Gln3 Transcription Activator Are Cumulatively Required for Control of Its Cytoplasmic Sequestration.</title>
<author>
<name sortKey="Rai, Rajendra" sort="Rai, Rajendra" uniqKey="Rai R" first="Rajendra" last="Rai">Rajendra Rai</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Tate, Jennifer J" sort="Tate, Jennifer J" uniqKey="Tate J" first="Jennifer J" last="Tate">Jennifer J. Tate</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Cooper, Terrance G" sort="Cooper, Terrance G" uniqKey="Cooper T" first="Terrance G" last="Cooper">Terrance G. Cooper</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163 tcooper@uthsc.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis</wicri:regionArea>
<wicri:noRegion>Memphis</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">G3 (Bethesda, Md.)</title>
<idno type="eISSN">2160-1836</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence (MeSH)</term>
<term>Amino Acid Substitution (MeSH)</term>
<term>Binding Sites (MeSH)</term>
<term>Conserved Sequence (MeSH)</term>
<term>Cytoplasm (metabolism)</term>
<term>Gene Expression Regulation, Fungal (MeSH)</term>
<term>Hydrophobic and Hydrophilic Interactions (MeSH)</term>
<term>Mutation (MeSH)</term>
<term>Phosphorylation (MeSH)</term>
<term>Protein Binding (MeSH)</term>
<term>Protein Interaction Domains and Motifs (MeSH)</term>
<term>Protein Transport (MeSH)</term>
<term>Proto-Oncogene Proteins c-myc (genetics)</term>
<term>Proto-Oncogene Proteins c-myc (metabolism)</term>
<term>Saccharomyces cerevisiae Proteins (chemistry)</term>
<term>Saccharomyces cerevisiae Proteins (genetics)</term>
<term>Saccharomyces cerevisiae Proteins (metabolism)</term>
<term>Stress, Physiological (genetics)</term>
<term>Transcription Factors (chemistry)</term>
<term>Transcription Factors (genetics)</term>
<term>Transcription Factors (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cytoplasme (métabolisme)</term>
<term>Facteurs de transcription (composition chimique)</term>
<term>Facteurs de transcription (génétique)</term>
<term>Facteurs de transcription (métabolisme)</term>
<term>Interactions hydrophobes et hydrophiles (MeSH)</term>
<term>Liaison aux protéines (MeSH)</term>
<term>Motifs et domaines d'intéraction protéique (MeSH)</term>
<term>Mutation (MeSH)</term>
<term>Phosphorylation (MeSH)</term>
<term>Protéines de Saccharomyces cerevisiae (composition chimique)</term>
<term>Protéines de Saccharomyces cerevisiae (génétique)</term>
<term>Protéines de Saccharomyces cerevisiae (métabolisme)</term>
<term>Protéines proto-oncogènes c-myc (génétique)</term>
<term>Protéines proto-oncogènes c-myc (métabolisme)</term>
<term>Régulation de l'expression des gènes fongiques (MeSH)</term>
<term>Sites de fixation (MeSH)</term>
<term>Stress physiologique (génétique)</term>
<term>Substitution d'acide aminé (MeSH)</term>
<term>Séquence conservée (MeSH)</term>
<term>Séquence d'acides aminés (MeSH)</term>
<term>Transport des protéines (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Saccharomyces cerevisiae Proteins</term>
<term>Transcription Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Proto-Oncogene Proteins c-myc</term>
<term>Saccharomyces cerevisiae Proteins</term>
<term>Transcription Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Facteurs de transcription</term>
<term>Protéines de Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Stress, Physiological</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Facteurs de transcription</term>
<term>Protéines de Saccharomyces cerevisiae</term>
<term>Protéines proto-oncogènes c-myc</term>
<term>Stress physiologique</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cytoplasm</term>
<term>Proto-Oncogene Proteins c-myc</term>
<term>Saccharomyces cerevisiae Proteins</term>
<term>Transcription Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cytoplasme</term>
<term>Facteurs de transcription</term>
<term>Protéines de Saccharomyces cerevisiae</term>
<term>Protéines proto-oncogènes c-myc</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Amino Acid Substitution</term>
<term>Binding Sites</term>
<term>Conserved Sequence</term>
<term>Gene Expression Regulation, Fungal</term>
<term>Hydrophobic and Hydrophilic Interactions</term>
<term>Mutation</term>
<term>Phosphorylation</term>
<term>Protein Binding</term>
<term>Protein Interaction Domains and Motifs</term>
<term>Protein Transport</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Interactions hydrophobes et hydrophiles</term>
<term>Liaison aux protéines</term>
<term>Motifs et domaines d'intéraction protéique</term>
<term>Mutation</term>
<term>Phosphorylation</term>
<term>Régulation de l'expression des gènes fongiques</term>
<term>Sites de fixation</term>
<term>Substitution d'acide aminé</term>
<term>Séquence conservée</term>
<term>Séquence d'acides aminés</term>
<term>Transport des protéines</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A remarkable characteristic of nutritional homeostatic mechanisms is the breadth of metabolite concentrations to which they respond, and the resolution of those responses; adequate but rarely excessive. Two general ways of achieving such exquisite control are known: stoichiometric mechanisms where increasing metabolite concentrations elicit proportionally increasing responses, and the actions of multiple independent metabolic signals that cumulatively generate appropriately measured responses. Intracellular localization of the nitrogen-responsive transcription activator, Gln3, responds to four distinct nitrogen environments: nitrogen limitation or short-term starvation, i.e., nitrogen catabolite repression (NCR), long-term starvation, glutamine starvation, and rapamycin inhibition of mTorC1. We have previously identified unique sites in Gln3 required for rapamycin-responsiveness, and Gln3-mTor1 interaction. Alteration of the latter results in loss of about 50% of cytoplasmic Gln3 sequestration. However, except for the Ure2-binding domain, no evidence exists for a Gln3 site responsible for the remaining cytoplasmic Gln3-Myc(13) sequestration in nitrogen excess. Here, we identify a serine/threonine-rich (Gln3477-493) region required for effective cytoplasmic Gln3-Myc(13) sequestration in excess nitrogen. Substitutions of alanine but not aspartate for serines in this peptide partially abolish cytoplasmic Gln3 sequestration. Importantly, these alterations have no effect on the responses of Gln3-Myc(13) to rapamycin, methionine sulfoximine, or limiting nitrogen. However, cytoplasmic Gln3-Myc(13) sequestration is additively, and almost completely, abolished when mutations in the Gln3-Tor1 interaction site are combined with those in Gln3477-493 cytoplasmic sequestration site. These findings clearly demonstrate that multiple individual regulatory pathways cumulatively control cytoplasmic Gln3 sequestration.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26976442</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>11</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2160-1836</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>6</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2016</Year>
<Month>05</Month>
<Day>03</Day>
</PubDate>
</JournalIssue>
<Title>G3 (Bethesda, Md.)</Title>
<ISOAbbreviation>G3 (Bethesda)</ISOAbbreviation>
</Journal>
<ArticleTitle>Multiple Targets on the Gln3 Transcription Activator Are Cumulatively Required for Control of Its Cytoplasmic Sequestration.</ArticleTitle>
<Pagination>
<MedlinePgn>1391-408</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1534/g3.116.027615</ELocationID>
<Abstract>
<AbstractText>A remarkable characteristic of nutritional homeostatic mechanisms is the breadth of metabolite concentrations to which they respond, and the resolution of those responses; adequate but rarely excessive. Two general ways of achieving such exquisite control are known: stoichiometric mechanisms where increasing metabolite concentrations elicit proportionally increasing responses, and the actions of multiple independent metabolic signals that cumulatively generate appropriately measured responses. Intracellular localization of the nitrogen-responsive transcription activator, Gln3, responds to four distinct nitrogen environments: nitrogen limitation or short-term starvation, i.e., nitrogen catabolite repression (NCR), long-term starvation, glutamine starvation, and rapamycin inhibition of mTorC1. We have previously identified unique sites in Gln3 required for rapamycin-responsiveness, and Gln3-mTor1 interaction. Alteration of the latter results in loss of about 50% of cytoplasmic Gln3 sequestration. However, except for the Ure2-binding domain, no evidence exists for a Gln3 site responsible for the remaining cytoplasmic Gln3-Myc(13) sequestration in nitrogen excess. Here, we identify a serine/threonine-rich (Gln3477-493) region required for effective cytoplasmic Gln3-Myc(13) sequestration in excess nitrogen. Substitutions of alanine but not aspartate for serines in this peptide partially abolish cytoplasmic Gln3 sequestration. Importantly, these alterations have no effect on the responses of Gln3-Myc(13) to rapamycin, methionine sulfoximine, or limiting nitrogen. However, cytoplasmic Gln3-Myc(13) sequestration is additively, and almost completely, abolished when mutations in the Gln3-Tor1 interaction site are combined with those in Gln3477-493 cytoplasmic sequestration site. These findings clearly demonstrate that multiple individual regulatory pathways cumulatively control cytoplasmic Gln3 sequestration.</AbstractText>
<CopyrightInformation>Copyright © 2016 Rai et al.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rai</LastName>
<ForeName>Rajendra</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tate</LastName>
<ForeName>Jennifer J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cooper</LastName>
<ForeName>Terrance G</ForeName>
<Initials>TG</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163 tcooper@uthsc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM035642</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>05</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>G3 (Bethesda)</MedlineTA>
<NlmUniqueID>101566598</NlmUniqueID>
<ISSNLinking>2160-1836</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C071664">GLN3 protein, S cerevisiae</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016271">Proto-Oncogene Proteins c-myc</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D029701">Saccharomyces cerevisiae Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017124" MajorTopicYN="N">Conserved Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015966" MajorTopicYN="Y">Gene Expression Regulation, Fungal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D057927" MajorTopicYN="N">Hydrophobic and Hydrophilic Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016271" MajorTopicYN="N">Proto-Oncogene Proteins c-myc</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D029701" MajorTopicYN="N">Saccharomyces cerevisiae Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Gln3</Keyword>
<Keyword MajorTopicYN="Y">mTorC1</Keyword>
<Keyword MajorTopicYN="Y">methionine sulfoximine</Keyword>
<Keyword MajorTopicYN="Y">nitrogen limitation</Keyword>
<Keyword MajorTopicYN="Y">rapamycin</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>11</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26976442</ArticleId>
<ArticleId IdType="pii">g3.116.027615</ArticleId>
<ArticleId IdType="doi">10.1534/g3.116.027615</ArticleId>
<ArticleId IdType="pmc">PMC4856090</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Cell Cycle. 2013 Sep 15;12(18):2948-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23974112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2013 Sep 20;288(38):27243-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23935103</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2014 Jul 4;289(27):18999-9018</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24847055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Signal. 2014 Dec 16;7(356):ra120</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25515537</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genetics. 2015 Feb;199(2):455-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25527290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>G3 (Bethesda). 2015 Aug;5(8):1625-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26024867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genetics. 2015 Nov;201(3):989-1016</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26333687</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14866-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10611304</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1999 Dec 9;402(6762):689-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10604478</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Bacteriol. 1996 Aug;178(15):4734-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8755910</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 1999 Dec 15;13(24):3271-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10617575</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2000 Nov 17;275(46):35727-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10940301</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2001 Aug 24;276(34):32136-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11408486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2002 May 14;99(10):6784-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11997479</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2003 May 9;278(19):16878-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12624103</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2003 Jun;11(6):1467-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12820961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Cell. 2003 Nov;14(11):4342-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14551259</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Mar 12;279(11):10270-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14679193</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Apr 30;279(18):19294-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14970238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 1995 Feb 13;359(2-3):215-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7867803</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 1996 Aug 1;10(15):1904-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8756348</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1999 May 17;18(10):2782-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10329624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEMS Yeast Res. 2006 Mar;6(2):218-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16487345</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2006 Aug 9;25(15):3546-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16874307</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2006 Dec 8;281(49):37980-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17015442</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2007 Jun 22;282(25):18467-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17439949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W460-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17567614</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2008 Apr 4;283(14):8919-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18245087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2009 Jan 23;284(4):2522-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19015262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Genet. 2009 Jun;5(6):e1000515</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19521502</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2009 Sep 11;35(5):563-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19748353</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Cycle. 2010 Jan 15;9(2):221-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20023374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eukaryot Cell. 2010 Apr;9(4):592-601</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20154027</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2010 Jun 4;285(23):17880-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20378536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Cell. 2011 Nov;22(21):4124-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21900499</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2012 Apr 13;46(1):105-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22424774</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2012 Aug 24;287(35):29648-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22807443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genetics. 2012 Sep;192(1):73-105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22964838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Structure. 2012 Dec 5;20(12):2151-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23123112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2013 Jan 25;288(4):2789-804</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23223232</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Signal. 2013 May 28;6(277):ra42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23716719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Methods. 2013 Jul;10(7):676-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23749301</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEMS Microbiol Rev. 2014 Mar;38(2):254-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24483210</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Tennessee</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Tennessee">
<name sortKey="Rai, Rajendra" sort="Rai, Rajendra" uniqKey="Rai R" first="Rajendra" last="Rai">Rajendra Rai</name>
</region>
<name sortKey="Cooper, Terrance G" sort="Cooper, Terrance G" uniqKey="Cooper T" first="Terrance G" last="Cooper">Terrance G. Cooper</name>
<name sortKey="Tate, Jennifer J" sort="Tate, Jennifer J" uniqKey="Tate J" first="Jennifer J" last="Tate">Jennifer J. Tate</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A63 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A63 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26976442
   |texte=   Multiple Targets on the Gln3 Transcription Activator Are Cumulatively Required for Control of Its Cytoplasmic Sequestration.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26976442" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020